Flagship Ventures Fund V General Partner LLC's Net Worth

$359 Million

Estimate Recalculated Feb 20, 2024 05:40PM EST

Who is Flagship Ventures Fund V General Partner LLC?

Flagship Ventures Fund V General Partner LLC has an estimated net worth of $359 Million. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., Kaleido Biosciences, Inc., Omega Therapeutics, Inc., Foghorn Therapeutics Inc., Denali Therapeutics Inc., Codiak BioSciences, Inc., Sigilon Therapeutics, Inc., Evelo Biosciences, Inc., and Rubius Therapeutics, Inc..

SEC CIK

Flagship Ventures Fund V General Partner LLC's CIK is 0001724575

Past Insider Trading and Trends

2020 was Flagship Ventures Fund V General Partner LLC's most active year for acquiring shares with 17 total transactions. Flagship Ventures Fund V General Partner LLC's most active month to acquire stocks was the month of February. 2023 was Flagship Ventures Fund V General Partner LLC's most active year for disposing of shares, totalling 18 transactions. Flagship Ventures Fund V General Partner LLC's most active month to dispose stocks was the month of July. 2021 saw Flagship Ventures Fund V General Partner LLC paying a total of $26,089,973.00 for 58,154,228 shares, this is the most they've acquired in one year. In 2023 Flagship Ventures Fund V General Partner LLC cashed out on 13,527,995 shares for a total of $17,962,115.86, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.155

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-32.03%
-11.78M
25M
Sep 13
Form 4
-3.22%
-403.76K
$6.27
-$2,532,858.32
12.12M
Jun 6 - Jun 7
Form 4
-4.17%
-545.24K
$6.47
-$3,527,275.14
12.53M
May 24 - May 26
Form 4
34.24M
34.24M
Feb 8
Form 3
0
0
No matching records found

Kaleido Biosciences, Inc. (KLDO) Snapshot price: $0.000001

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.12%
12M
$15.00
$13,999,995.00
37.48M
Mar 4
Form 3
0
0
No matching records found

Foghorn Therapeutics Inc. (FHTX) Snapshot price: $3.15

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
12.67M
$16.00
12.67M
Oct 27
Form 3
0
0
No matching records found

Denali Therapeutics Inc. (DNLI) Snapshot price: $17.11

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,754.00%
8.61M
8.92M
Dec 12
Form 3
0
0
No matching records found

Codiak BioSciences, Inc. (CDAKQ) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+44.00%
933.33K
3.05M
Sep 15
Form 4
+148.76%
2.12M
$15.00
3.55M
Oct 16
Form 3
0
0
No matching records found